The Effect of Angiotensin Converting Enzyme (ACE) I/D Polymorphism on Atherosclerotic Cardiovascular Disease and Cardiovascular Mortality Risk in Non-Hemodialyzed Chronic Kidney Disease: The Mediating Role of Plasma ACE LevelHendri Susilo, Delvac Oceandy, Budi Susetyo Pikir et al.|Genes|2022Cited by 21
The Role of Plasma Interleukin-6 Levels on Atherosclerotic Cardiovascular Disease and Cardiovascular Mortality Risk Scores in Javanese Patients with Chronic Kidney DiseaseHendri Susilo, Delvac Oceandy, Mochammad Thaha et al.|Journal of Personalized Medicine|2022Cited by 16
Brown Tumour in Chronic Kidney Disease: Revisiting an Old Disease with a New PerspectiveDjoko Santoso, Pancras C.W. Hogendoorn, Siprianus Ugroseno Yudho Bintoro et al.|Cancers|2023Cited by 8
Relationship Between ACE I/D Polymorphism and Cardiovascular Mortality Risk in Non-Hemodialyzed Chronic Kidney DiseaseHendri Susilo, Delvac Oceandy, Budi Susetyo Pikir et al.|Preprints.org|2022Cited by 6
Type II Diabetes as the Main Risk Factor of Arterial Stiffness in Chronic Kidney Disease PatientsHendri Susilo, Citrawati Dyah Kencono Wungu, Budi Susetyo Pikir et al.|Unknown|2022Cited by 3